-
From Danielle Solar
| 14 14 playsDr. Jackson teaches human biology in the department of Natural and Applied Sciences. They quickly updated the course to reflect the pandemic during the spring semester… -
From Danielle Solar
| 9 9 playsFred Ledley explains the Center for Integration of Science's current research around "the financing and public policy related to drug development" as it… -
From Danielle Solar
| 9 9 playsMatthew Jackson works in the Center for Integration of Science and Industry on the maturity of underlying basic research, funding and drug development. Dr. Jackson is… -
From Kaltura MediaUser
| 68 68 playsDr. Edward J. Benz, Jr., MD, former president and CEO of Dana-Farber Cancer Institute talks about Dana Farber’s role in healthcare innovation and how this large… -
From Kaltura MediaUser
| 50 50 playsA fireside chat on the financialization of the pharmaceutical industry and its effects on drugs by Economist Dr. William Lazonick. The event is organized by the Center… -
From Kaltura MediaUser
| 22 22 playsA fireside chat with Dr. Gary J. Nabel, M.D., Ph.D. Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North… -
From Kaltura MediaUser
| 99 99 playsDr. Sharp will explore the dynamic intersections of science with business and public policy, and how these interactions advance the public interest. We are honored to… -
From Kaltura MediaUser
| 42 42 playsEkaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark… -
From Kaltura MediaUser
| 91 91 playsBentley alumnus Lance Colwell, and MIldon Farrwell, from Biogen, discuss the commercial launch of a revolutionary new product, Spiranza -
From Kaltura MediaUser
| 48 48 playsStephen Bonner, former CEO & Director, Center Treatment Centers of America